SANUWAVE Health Relocates Principal Executive Offices to Minnesota

TL;DR

**SANUWAVE Health moved its main office to Minnesota, signaling potential operational changes.**

AI Summary

SANUWAVE Health, Inc. filed an 8-K on January 10, 2024, indicating a change in their principal executive offices from Suwanee, GA to 11495 Valley View Road, Eden Prairie, Minnesota 55344. This move suggests a potential operational shift or expansion, which could impact the company's efficiency or strategic focus. Investors should monitor future filings for details on the reasons behind this relocation and its potential effects on the company's financial performance and growth prospects.

Why It Matters

A change in principal executive offices can signal strategic shifts, cost-saving initiatives, or expansion plans, all of which can influence a company's operational efficiency and future profitability.

Risk Assessment

Risk Level: low — The filing primarily reports an administrative change of address, which typically carries a low direct risk to investors.

Analyst Insight

A smart investor would note this administrative change and look for subsequent filings or company announcements that might explain the strategic implications of relocating their principal executive offices, as this could signal broader operational shifts.

Key Players & Entities

• SANUWAVE Health, Inc. (company) — the registrant filing the 8-K
• January 10, 2024 (date) — date of the earliest event reported
• Suwanee, GA (location) — former business address
• 11495 Valley View Road, Eden Prairie, Minnesota 55344 (location) — new principal executive offices address

Forward-Looking Statements

• SANUWAVE Health, Inc. will provide more details on the strategic rationale behind the office relocation in future investor communications or filings. (SANUWAVE Health, Inc.) — medium confidence, target: 2024-03-31

FAQ

Filing Documents

• ef20018511_8k.htm (8-K) — 27KB
• ef20018511_ex99-1.htm (EX-99.1) — 9KB
• image00001.jpg (GRAPHIC) — 6KB
• 0001140361-24-001728.txt ( ) — 170KB
• snwv-20240110.xsd (EX-101.SCH) — 4KB
• snwv-20240110_lab.xml (EX-101.LAB) — 20KB
• snwv-20240110_pre.xml (EX-101.PRE) — 14KB
• ef20018511_8k_htm.xml (XML) — 4KB

02

Item 2.02 Results of Operations and Financial Condition. On January 10, 2024, SANUWAVE Health, Inc., a Nevada corporation (the "Company" ), issued a press release announcing certain preliminary financial results for the quarter and fiscal year ended December 31, 2023. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release dated January 10, 2024 104 Cover Page Interactive Data File––the cover page XBRL tags are embedded within the Inline XBRL document.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SANUWAVE HEALTH, INC. Dated: January 10, 2024 By: /s/ Toni Rinow Name: Toni Rinow Title: Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR